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Abstract
Background: Canonical Notch signaling is initiated when ligand binding induces proteolytic release of the intracellular part
of Notch (ICN) from the cell membrane. ICN then travels into the nucleus where it drives the assembly of a transcriptional
activation complex containing the DNA-binding transcription factor CSL, ICN, and a specialized co-activator of the
Mastermind family. A consensus DNA binding site motif for the CSL protein was previously defined using selection-based
methods, but whether subsequent association of Notch and Mastermind-like proteins affects the DNA binding preferences
of CSL has not previously been examined.
Principal Findings: Here, we utilized protein-binding microarrays (PBMs) to compare the binding site preferences of isolated
CSL with the preferred binding sites of CSL when bound to the CSL-binding domains of all four different human Notch
receptors. Measurements were taken both in the absence and in the presence of Mastermind-like-1 (MAML1). Our data show
no detectable difference in the DNA binding site preferences of CSL before and after loading of Notch and MAML1 proteins.
Conclusions/Significance: These findings support the conclusion that accrual of Notch and MAML1 promote transcriptional
activation without dramatically altering the preferred sites of DNA binding, and illustrate the potential of PBMs to analyze
the binding site preferences of multiprotein-DNA complexes.
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Introduction
CSL(genenameRBPJ)isaDNA-bindingtranscriptionfactorthat
orchestrates the transcriptional response to Notch receptor activa-
tion.AfterligandbindinginducesproteolysisofNotch,ICNmigrates
to the nucleus, where it binds to CSL and recruits a protein of the
Mastermind family to upregulate transcription of a typical target
gene [1,2,3]. In some contexts, CSL may act as a transcriptional
repressor in the absence of activated Notch, either by recruiting
histone modifying enzymes or by direct interaction with other
corepressors [4,5,6]. Formation of a complex between Notch and
CSL creates a binding groove that captures a Mastermind protein
[7,8], which in turn is thought to recruit generalized transcriptional
coactivators such as p300/CBP and the basal transcription
machinery to induce target gene expression [9,10,11].
The interaction of Notch with CSL is a thus crucial step in the
signaling pathway because the loading of CSL onto DNA dictates
which genes are transcribed in response to assembly of Notch-
CSL-MAML complexes. The preferred DNA binding sites for
murine CSL and for the protein LAG-1, which is the homologue
of CSL in C. elegans, have been analyzed by electrophoretic
mobility shift assay, selection-based methods, and a bacterial one-
hybrid system. These methods led to the identification of an eight
base-pair consensus binding sequence of CGTGGGAA [12].
More recently, a quantitative thermodynamic analysis of the
interaction between CSL and the two individual CSL binding sites
in the HES-1 promoter have revealed subtle differences in the
binding affinities of CSL for each DNA binding site [13]. Studies
investigating the loading of Suppressor-of-hairless (Su(H), the
Drosophila CSL homologue) onto DNA in cultured fly cells have
shown that the occupancy of DNA binding sites by CSL increases
after a pulse of Notch activation [14,15]. However, it is not yet clear
whether this change results from increased stability of DNA-bound
complexes or alterations in binding site preferences, as none of these
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Notch and Mastermind-like proteins might alter the DNA binding
site preferences of CSL and/or its binding affinities for different
DNA sequences.
Here we present a new strategy to analyze the binding of
multiprotein CSL complexes to DNA. We exploited the universal
protein binding microarray (PBM) technology [16,17,18,19] to
analyze and compare the DNA binding preferences of isolated
CSL for DNA with the site preferences for multiprotein Notch-
CSL and Mastermind-Notch-CSL complexes. These studies show
that the binding of Notch and the subsequent recruitment of
Mastermind-like-1 (MAML-1) do not detectably change the
binding specificities of CSL, supporting the idea that the formation
of Notch transcriptional activation complexes rely primarily on the
binding of DNA by CSL to dictate target-site specificity.
Results
In this study, we used PBMs to analyze the DNA-binding site
preferences of CSL alone and in complex with the four different
Notch receptors and human MAML-1. Each custom-designed,
universal spot on the 4644K 60-mer oligonucleotide array
contains 26 distinct, overlapping 10-mers, resulting in not only
complete but also highly redundant coverage of all 8-bp sequences:
within each individual chamber containing approximately 44,000
60-mers, there are more than 1.1 million 10-mers displayed, and
each possible 8-mer DNA sequence variant is present in either
orientation at 32 spots. For each 8-mer, we calculate its median
signal intensity over the 32 spots at which it is present and also a
rank-based, PBM enrichment score (E-score), ranging from 20.5
(worst) to +0.5 (best), that indicates the preference of a protein or
protein complex for that 8-mer [20]. Prior comparisons between
PBM signal intensities and dissociation constant data for several
eukaryotic proteins indicate that relative Kd values are approxi-
mately inversely correlated with the median signal intensity of
each k-mer analyzed, indicating that relative signal intensities
estimate DNA binding preferences [20].
To identify bound complexes, either the CSL protein, or the
RAMANK portion of the Notch protein (hereafter referred to as
Notch), was prepared as a glutathione-S-transferase (GST) fusion,
which was detected with an anti-GST antibody coupled to an
Alexa-488 fluorophore. The different CSL, Notch, and MAML-1
proteins tested in these studies are illustrated in Figure 1.
To assess the effects of added Notch and MAML-1 on the
specificity of CSL for its recognized DNA target motifs, we used a
microarray with 4 chambers, each containing a different preformed
protein complex. We used as a negative control GST-Notch1 alone,
which lacks the ability to bind DNA. Analysis of the data from the
PBM chamber incubated with CSL alone revealed an 8-bp binding
site consensus of YGTGGGAA (Figure 2A), which matches
previous reports [12]. The comprehensive binding data also reveal
a substantial amount of degeneracy at Y1, G2, G5, and A8, with
more stringent constraints at T3, G4, G6, and A7.
In the same experiments, we also determined the DNA binding
site preferences of CSL-Notch1 and CSL-Notch1-MAML-1
complexes and compared these results with the site preferences
of CSL alone (Figure 2B, C). The DNA binding motif recognized
by CSL was preserved in these complexes, and the site preferences
were not detectably affected by Notch1 or MAML-1 loading.
GST-Notch1, which was the negative control for these assays, did
not exhibit detectable binding to the PBM (Figure 2D).
A more comprehensive statistical analysis of the E-scores of all
32,896 ungapped 8-mers (reverse complements are merged),
comparing different pairs of conditions (CSL versus Notch1-CSL,
and CSL versus MAML-1-Notch1-CSL), shows that the E-scores
of the different 8-mers correlate very tightly among the three
conditions, providing additional support for the conclusion that
the distribution of bound sites is not altered upon loading of
Notch1 and MAML-1 (Figure 3).
To confirm that our approach detected multiprotein complexes
bound to the DNA, and not merely GST-CSL that was no longer
in complex with Notch1 (or MAML-1), we also assembled
complexes using hexahistidine-tagged CSL, and prepared a
GST-Notch1 fusion protein for use in place of unlabeled Notch1.
This scheme allowed for indirect detection of CSL binding to
DNA by monitoring the subsequent capture of GST-Notch1 by
CSL-DNA complexes [21]. Again, the observed DNA binding site
preferences closely resembled those seen upon binding of GST-
CSL alone, with GST-Notch1 alone serving as the negative
control (Figure 4). This experiment provides an unambiguous
demonstration that it is possible to monitor the loading of multiple
protein components onto DNA using PBMs.
Finally, we investigated how incorporating the RAMANK
domain from the four different Notch homologues (Notch1-4) into
CSL-containing complexes influenced the DNA-binding proper-
ties of CSL. This experiment was performed with preassembled
complexes of unlabeled CSL, GST-Notch, and MAML-1 to
ensure that all detected complexes included both Notch and CSL,
with the presence of MAML-1 inferred based on previous studies
Figure 1. Schematic illustrating the protein constructs used in
this study. Abbreviations are: RAMANK, a Notch polypeptide including
the RAM and ankyrin repeat domains of Notch; MAML-1, Mastermind-
like-1; GST, glutathione S-transferase; 66His, hexahistidine tag.
doi:10.1371/journal.pone.0015034.g001
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differences among the difference complexes. We also performed
an analysis of the comprehensive 8-mer PBM data to look for
reproducible trends (here, 6-mers) that may be consistently favored
or disfavored for binding by any of the protein complexes as
compared to GST-CSl alone. The data do not reveal any
detectable differences – either by examination of the PBM-derived
motifs or by a comprehensive search for potential preferred 6-mers
(see Methods) – in the binding specificities of CSL for DNA when
it is assembled in complexes with the four different Notch
receptors, nor for the different Notch complexes when compared
with one another (Figure 5 and Supplementary Figure S1), leading
to the conclusion that CSL DNA binding site preferences are
essentially unaffected by complexation with any of the human
Notch proteins (see also Supplementary Figure S2).
Discussion
Here, we report a comprehensive study designed to uncover
how DNA binding-site preferences are affected when CSL is part
of a multiprotein complex. Our approach relied on the use of
PBMs, a method that permits rapid, high-throughput character-
ization of the in vitro DNA binding specificities of proteins
[16,17,18]. Universal PBM experiments covering all possible 10-
mer binding sites previously have been used to identify the DNA
binding preferences of over 400 eukaryotic DNA binding proteins
from over 24 structural classes [20,21,23,24,25,26,27,28,29].
Here, PBM experiments performed with the Notch pathway
transcription factor CSL reveal that the preferred DNA binding
site for CSL is YGTGGGAA. This consensus site conforms to the
published consensus determined using traditional selection meth-
ods [12]. The comprehensive, high resolution nature of the PBM
data provide additional insight into the details of the DNA binding
specificity of CSL: the four nucleotides underlined in the consensus
sequence are nearly invariant among the bound sequences,
whereas nucleotide substitutions at the other four positions are
tolerated better.
The other issue addressed in these studies was whether or not
the DNA site preferences of CSL vary upon complexation with
Notch and Mastermind proteins. Prior studies using universal
PBMs examined the DNA binding preferences of either individual
proteins or unambiguous dimers [20,21,23,24,25,26,27,28,29]. To
our knowledge, our study is the first to use such PBMs to
investigate the potential influence of the addition of protein
cofactors into multiprotein complexes on the DNA binding
specificity of a transcription factor. Strikingly, there was no
apparent distinction among the 8-mer binding preferences of any
of the CSL-Notch or CSL-Notch-MAML-1 complexes examined
in this study. These results suggest that protein-protein interactions
with other transcriptional regulators and/or epigenetic mecha-
nisms are the key events that control the distribution of genomic
sites bound by the various CSL and Notch transcription
complexes. Further investigation is needed to uncover how the
distribution of bound sites is regulated in cells responding to Notch
activation in vivo.
Materials and Methods
Protein expression and purification
GST-66His-TEV-CSL-(9-435) was constructed by ligation
independent cloning into the plasmid pET-41 Ek/LIC (Novagen)
and expressed in E. coli Rosetta pLysS (Novagen). Cells were
induced at an O.D. (600 nm) of 0.8 with 0.5 mM IPTG at room
temperature, overnight. Cell pellets were resuspended in 25 mL of
buffer 1 (0.5 M NaCl, 0.05 M Tris-HCl pH 8.5, 5 mM bME) and
sonicated. Proteins from the cleared lysate were first affinity
purified by incubating the lysates in batch with 5 mL of Ni-NTA
Agarose beads (Qiagen) for 1 hour at 4uC. The Ni-NTA agarose
beads were pelleted and the immobilized proteins were eluted with
250 mM imidazole. GST-CSL was further purified by binding to
10 mL of glutathione sepharose resin (GE Healthcare) pre-
equilibrated with buffer 1. Beads were washed with buffer 1 and
the GST fused CSL was eluted with 20 mM glutathione in buffer
1. The obtained protein sample was then concentrated and
Figure 2. Accrual of Notch1 and MAML-1 does not detectably alter the binding site preferences of GST-CSL. Protein mixtures were
applied to PBMs, and bound complexes were detected with an Alexa488-conjugated anti-GST antibody (see Materials and Methods). Columns from
left to right show: input components, strategy used to detect immobilized proteins, zoom-in on portions of microarray images, and a DNA sequence
logo representing the bound 8-mers [20]. The protein mixtures incubated in separate chambers of the same microarray chip were as follows: A) GST-
CSL alone, B) GST-CSL/Notch1 complexes, C) GST-CSL/Notch1/MAML-1 complexes, and D) GST-Notch1 alone. C: CSL; N: Notch; M: MAML. Cartoons
representing CSL, Notch, and MAML proteins are colored green, blue, and red, respectively.
doi:10.1371/journal.pone.0015034.g002
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5 mM DTT). CSL-His6, MAML and Notch proteins were
expressed and purified as previously described [8,30].
Protein binding microarray experiments
Universal ‘all 10-mer’ microarrays were synthesized (Agilent
Technologies, AMADID # 015681) and converted to double-
stranded DNA arrays by primer extension as described previously
[20,24]. Double-stranded microarrays were premoistened in
PBS+0.01% (vol/vol) Triton X-100 for 5 min and blocked with
2% (wt/vol) nonfat dried milk (Sigma) in PBS for 1 h. Microarrays
were then washed once with PBS+0.1% (vol/vol) Tween-20 for
5 min and once with PBS+0.01% (vol/vol) Triton X-100 for
2 min. The different protein mixtures were incubated for
30 minutes at room temperature in a 150 ml protein binding
reaction containing 2% (wt/vol) milk, 51.3 ng/ml salmon testes
DNA (Sigma), 0.2 mg/ml bovine serum albumin (New England
Biolabs) in PBS. For the experiment reported in Figure 4 using
GST-Notch1, complexes were formed at a 1:1:5 CSL
(1.8 mM):Notch (1.8 mM):MAML (9 mM) molar ratio. For the
experiments reported in Figures 2, 5, and Supplementary Figure
S1, protein concentrations for each component were 0.2 mM, and
complexes were formed at a 1:1:1 CSL:Notch:MAML molar ratio;
experiments performed at a 1:1:5 molar ratio gave binding-site
logos for Notch1 complexes that were not detectably distinguish-
able from those reported in Figure 2 (not shown). Preincubated
protein binding mixtures were applied to the microarrays and
incubated for 1 h at room temperature. Protein concentrations
were optimized for different detection methods as listed below.
Microarrays were washed once with PBS+0.5% (vol/vol) Tween-
20 for 3 min, and then once with PBS+0.01% (vol/vol) Triton X-
100 for 2 min. Alexa488-conjugated antibodies were diluted in
PBS+2% (vol/vol) milk and applied to the microarray for 15 min
(Figure 2) or 60 min (Figures 4, 5 and Supplementary Figure S1) in
the dark. Finally, microarrays were washed twice with PBS+0.05%
(vol/vol) Tween-20 for 2 min and once with PBS for 2 min.
Washed slides were spun dry by centrifugation at 40 g for 5 min
and analyzed. Alexa488-conjugated rabbit polyclonal antibody to
GST (Molecular Probes, cat # A-11131) was used at a
concentration of 50 mg/ml.
Microarray analysis
Microarray analysis, data normalization, and DNA binding
specificity analysis were performed as previously described [20,31].
Briefly, all microarrays were scanned (GSI Lumonics ScanArray
5000) at three different laser power settings. Microarray TIFF
images were quantified using GenePix Pro Version 6.0 software
(Molecular Devices). Data from multiple scans of the same slide
were combined using masliner (Micro-Array LINEar Regression)
software [30]. For each spot, background-subtracted median
intensities were calculated using the median local background, and
the signal intensity at each spot was normalized by the
corresponding relative amount of double-stranded DNA. Deter-
mination of binding preferences for all 8-mers and derivation of
associated DNA binding site position weight matrices were
calculated using the Universal PBM Analysis Suite and the
Seed-and-Wobble motif derivation algorithm [20,31]. The data
from all experiments reported here is publicly available in the
UNIPROBE database at http://the_brain.bwh.harvard.edu/
uniprobe/, and are MIAME compliant for all applicable criteria.
For each PBM experiment, for each 6-mer we also averaged the
E-scores of all ungapped 8-mers that contain it (typically, there are
32 such 8-mers for each 6-mer). To search for potential ‘TF-
preferred’ k-mers [25], we then searched for 6-mers bound by
GST-CSL at PBM enrichment score (E).0.37 (bound at a 0.1%
false discovery rate) and bound by a particular protein complex at
E,0.32 (i.e., not bound well), and separately for 6-mers bound by
a particular protein complex at E.0.37 and bound by GST-CSL
at E,0.32. We repeated this analysis for each PBM experiment
(Supplementary Figure S2). At these enrichment score thresholds,
we did not obtain any 6-mers artifactually identified as ‘preferred’
when comparing independent, duplicate PBM experiments
performed for two different protein complexes (duplicate PBM
Figure 3. Comparison of sequence preferences for GST-CSL
alone compared with GST-CSL in complexes containing Notch1
and MAML-1. Scatter plots compare PBM enrichment scores of
individual 8-mers for: A) GST-CSL versus GST-CSL/Notch1 complexes, B)
GST-CSL versus GST-CSL/Notch1/MAML-1 complexes. Enrichment
scores were determined from the experiments shown in Figure 2.
doi:10.1371/journal.pone.0015034.g003
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experiments for GST-Notch2+CSL+MM).
Supporting Information
Figure S1 Notch 4 does not detectably alter the DNA binding-
site preferences of CSL-His6. DNA binding specificity motifs and
8-mer PBM enrichment scores were calculated for complexes
comprised of A) CSL-His6 and GST-Notch2, B) CSL-His6 and
GST-Notch4 and C) an empty chamber as a negative control.
Motifs were derived using the Seed-and-Wobble algorithm as
previously described [20,31].
(PDF)
Figure S2 Heatmap of ungapped 8-mers bound in PBMs.
Shown are all ungapped 8-mers bound at a PBM enrichment score
of at least 0.30 in at least 1 PBM experiment in our data set. PBM
Figure 4. Detection of CSL-Notch1 complexes on DNA by monitoring the capture of GST-Notch-1. Columns from left to right show:
experimental design, strategy for detection of immobilized complexes, PBM scans, and a DNA sequence logo representing the bound 8-mers. The
protein mixtures incubated in separate chambers of the same microarray chip were as follows: A) GST-Notch1/CSL-His6 complexes, B) GST-Notch1/
CSL-His6/MAML complexes, and C) GST-Notch1 alone (see methods). C: CSL; N: Notch; M: MAML. Cartoons representing CSL-His6, Notch, and MAML
proteins are colored green, blue, and red, respectively.
doi:10.1371/journal.pone.0015034.g004
Figure 5. Notch receptors 1–3 do not detectably alter the DNA binding-site preferences of CSL-His6. DNA binding specificity motifs and
8-mer PBM enrichment scores were calculated for complexes comprised of A) CSL-His6 and GST-Notch1, B) CSL-His6 and GST-Notch2 and C) CSL-His6
and GST-Notch3. Motifs were derived using the Seed-and-Wobble algorithm as previously described [20,31].
doi:10.1371/journal.pone.0015034.g005
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in ungapped 8-mer binding profiles; ungapped 8-mers are
clustered along the y-axis according to similarity across PBM
experiments. Color bar indicates enrichment scores.
(PDF)
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